Viewing Study NCT04915612

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:18 PM
Ignite Modification Date: 2026-03-13 @ 12:24 PM
Study NCT ID: NCT04915612
Status: COMPLETED
Last Update Posted: 2025-04-27
First Post: 2021-02-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome View
None Recurrent Acute Myeloid Leukemia View
None Refractory Acute Myeloid Leukemia View
None Secondary Acute Myeloid Leukemia View
Keywords: